← Leaderboards
Peter J Tontonoz
University Of California Los Angeles
$38,870,418
Attributed
$40,521,954
Total exposure
23
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,521,954 · 23
By mechanism
R01$21,596,185 · 11
P01$13,581,560 · 6
P30$4,976,610 · 5
T32$367,599 · 1
Top collaborators
- Patrick G. Harran5 shared
- Andrea L Hevener1 shared
- Tamer Sallam1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Jesus Antonio Araujo$8,247,283
- William H. McBride$18,336,663
- Thomas A Vallim$9,550,774
- Peter A Edwards$10,102,590
- Linda L. Demer$9,283,629
Others in their field
Top investigators on “Lipids”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Alan M Fogelman · University Of California Los Angeles$57,458,120
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Adrian Hernandez · Duke University$50,769,596
- Garret A Fitzgerald · University Of Pennsylvania$50,340,498
- Richard A Gibbs · Baylor College Of Medicine$49,140,324
Research focus
LipidsLipid MetabolismPathway InteractionsMetabolic DiseasesGene ExpressionCellsMetabolismRegulationMolecularDiabetes MellitusIn VivoGenesResponseHomeostasisMetabolicSignal PathwayAtherosclerosisCholesterolSignal TransductionLinkTissuesPhysiologicalAffectTherapeutic Intervention
Grant awards (93)
Membrane cholesterol and vascular inflammation$773,259
R01 · FY2025 · HL · contact PI
Mechanisms of Dietary Nutrient Absorption$761,399
R01 · FY2025 · DK · contact PI
Mechanisms of nonvesicular cholesterol transport$727,059
R01 · FY2025 · HL · contact PI
Lipid storage and utilization in physiology and obesity$553,800
R01 · FY2025 · DK · contact PI
Pilot & Feasibility Program$382,047
P30 · FY2025 · DK · contact PI
Interdisciplinary Training Program in Metabolism (UCLA-ITPM)$367,599
T32 · FY2025 · DK
Mechanisms of nonvesicular cholesterol transport$727,059
R01 · FY2024 · HL · contact PI
Lipid storage and utilization in physiology and obesity$531,649
R01 · FY2024 · DK · contact PI
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism$470,178
R01 · FY2024 · DK · contact PI
Membrane homeostasis in adipose physiology and obesity$451,768
R01 · FY2024 · DK · contact PI
Pilot & Feasibility Program$409,683
P30 · FY2024 · DK · contact PI
Cellular cholesterol movement in cardiovascular disease$670,800
P01 · FY2023 · HL · contact PI
Lipid storage and utilization in physiology and obesity$553,800
R01 · FY2023 · DK · contact PI
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism$489,767
R01 · FY2023 · DK · contact PI
Membrane homeostasis in adipose physiology and obesity$470,590
R01 · FY2023 · DK · contact PI
Pilot & Feasibility Program$388,599
P30 · FY2023 · DK · contact PI
Cellular cholesterol movement in cardiovascular disease$670,800
P01 · FY2022 · HL · contact PI
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism$489,767
R01 · FY2022 · DK · contact PI
Membrane homeostasis in adipose physiology and obesity$470,590
R01 · FY2022 · DK · contact PI
Immune pathways in adipose thermogenesis$455,553
R01 · FY2022 · DK · contact PI
Pilot & Feasibility Program$388,632
P30 · FY2022 · DK · contact PI
Cellular cholesterol movement in cardiovascular disease$670,800
P01 · FY2021 · HL · contact PI
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis$514,800
R01 · FY2021 · HL · contact PI
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism$489,767
R01 · FY2021 · DK · contact PI
Membrane homeostasis in adipose physiology and obesity$484,590
R01 · FY2021 · DK · contact PI
Immune pathways in adipose thermogenesis$457,080
R01 · FY2021 · DK · contact PI
Pilot & Feasibility Program$388,664
P30 · FY2021 · DK · contact PI
Cellular cholesterol movement in cardiovascular disease$670,800
P01 · FY2020 · HL · contact PI
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis$514,800
R01 · FY2020 · HL · contact PI
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism$489,767
R01 · FY2020 · DK · contact PI
Immune pathways in adipose thermogenesis$457,080
R01 · FY2020 · DK · contact PI
Pilot & Feasibility Program$392,120
P30 · FY2020 · DK · contact PI
Cellular cholesterol movement in cardiovascular disease$670,800
P01 · FY2019 · HL · contact PI
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis$514,800
R01 · FY2019 · HL · contact PI
Immune pathways in adipose thermogenesis$457,080
R01 · FY2019 · DK · contact PI
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation$385,000
P01 · FY2019 · HL · contact PI
Pilot & Feasibility Program$352,638
P30 · FY2019 · DK · contact PI
Designed Small Molecule Inhibitors of Ghrelin O-Acyl Transferase$554,272
R01 · FY2018 · DK
Novel Pathways for Triglyceride Storage and Adipogenesis$538,528
P01 · FY2018 · HL · contact PI
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis$512,875
R01 · FY2018 · HL · contact PI
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis$389,810
R01 · FY2018 · HL · contact PI
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation$385,000
P01 · FY2018 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$385,000
R01 · FY2018 · HL · contact PI
Pilot & Feasibility Program$354,044
P30 · FY2018 · DK · contact PI
Designed Small Molecule Inhibitors of Ghrelin O-Acyl Transferase$554,272
R01 · FY2017 · DK
Novel Pathways for Triglyceride Storage and Adipogenesis$536,993
P01 · FY2017 · HL · contact PI
PILOT AND FEASIBILITY PROGRAM$387,497
P30 · FY2017 · DK · contact PI
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation$385,000
P01 · FY2017 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$385,000
R01 · FY2017 · HL · contact PI
Designed Small Molecule Inhibitors of Ghrelin O-Acyl Transferase$554,272
R01 · FY2016 · DK
Novel Pathways for Triglyceride Storage and Adipogenesis$530,054
P01 · FY2016 · HL · contact PI
PILOT AND FEASIBILITY PROGRAM$387,497
P30 · FY2016 · DK · contact PI
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation$385,000
P01 · FY2016 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$385,000
R01 · FY2016 · HL · contact PI
Designed Small Molecule Inhibitors of Ghrelin O-Acyl Transferase$595,852
R01 · FY2015 · DK
Novel Pathways for Triglyceride Storage and Adipogenesis$528,939
P01 · FY2015 · HL · contact PI
PILOT AND FEASIBILITY PROGRAM$387,497
P30 · FY2015 · DK · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$385,000
R01 · FY2015 · HL · contact PI
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation$385,000
P01 · FY2015 · HL · contact PI
The LXR-LPCAT3 pathway in metabolism, inflammation and disease$209,891
R01 · FY2015 · DK · contact PI
Designed Small Molecule Inhibitors of Ghrelin O-Acyl Transferase$554,272
R01 · FY2014 · DK
Novel Pathways for Triglyceride Storage and Adipogenesis$531,306
P01 · FY2014 · HL · contact PI
PILOT AND FEASIBILITY PROGRAM$392,279
P30 · FY2014 · DK · contact PI
PILOT AND FEASIBILITY PROGRAM$365,413
P30 · FY2013 · DK · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$321,801
R01 · FY2013 · HL · contact PI
Regulation of Lipid Metabolism and Inflammation by the Orphan Nuclear Receptors$308,268
P01 · FY2013 · HL · contact PI
Novel Pathways for Triglyceride Storage and Adipogenesis$461,251
P01 · FY2012 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$338,027
R01 · FY2012 · HL · contact PI
Regulation of Lipid Metabolism and Inflammation by the Orphan Nuclear Receptors$323,810
P01 · FY2012 · HL · contact PI
Novel Pathways for Triglyceride Storage and Adipogenesis$465,131
P01 · FY2011 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$341,441
R01 · FY2011 · HL · contact PI
Regulation of Lipid Metabolism and Inflammation by the Orphan Nuclear Receptors$323,810
P01 · FY2011 · HL · contact PI
Novel Pathways for Triglyceride Storage and Adipogenesis$474,394
P01 · FY2010 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$341,441
R01 · FY2010 · HL · contact PI
Regulation of Lipid Metabolism and Inflammation by the Orphan Nuclear Receptors$323,810
P01 · FY2010 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$262,534
R01 · FY2010 · HL · contact PI
Novel Pathways for Triglyceride Storage and Adipogenesis$472,413
P01 · FY2009 · HL · contact PI
Regulation of Lipid Metabolism and Inflammation by the Orphan Nuclear Receptors$347,710
P01 · FY2009 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$262,534
R01 · FY2009 · HL · contact PI
Novel Pathways for Triglyceride Storage and Adipogenesis$527,860
P01 · FY2008 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$262,534
R01 · FY2008 · HL · contact PI
Role of PPARdelta in Lipid Metabolism and Atherosclerosis$351,219
P01 · FY2007 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$262,534
R01 · FY2007 · HL · contact PI
Role of PPARdelta in Lipid Metabolism /Atherosclerosis$333,686
P01 · FY2006 · HL · contact PI
Nuclear Receptor Signaling Pathways in Atherogenesis$270,375
R01 · FY2006 · HL · contact PI
Role of PPARdelta in Lipid Metabolism /Atherosclerosis$318,867
P01 · FY2005 · HL
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESIS$226,951
R01 · FY2005 · HL
Role of PPARdelta in Lipid Metabolism /Atherosclerosis$307,176
P01 · FY2004 · HL
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESIS$226,951
R01 · FY2004 · HL
Role of PPARdelta in Lipid Metabolism /Atherosclerosis$297,335
P01 · FY2003 · HL
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESIS$226,951
R01 · FY2003 · HL
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESIS$150,879
R01 · FY2002 · HL
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESIS$329,714
R01 · FY2001 · HL